Abstract
Cytomegalovirus (CMV) retinitis is the most important blinding complication in patients with human immunodeficiency virus (HIV) infection or acquired immunodeficiency syndrome (AIDS). Before the introduction of the highly active or combination antiretroviral therapy (HAART), the incidence of CMV retinitis was as high as 45.3 per 1000 person-years (Schwarcz et al. 2013).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Arevalo JF, Mendoza AJ, Ferretti Y. Immune recovery uveitis in AIDS patients with cytomegalovirus retinitis treated with highly active antiretroviral therapy in Venezuela. Retina (Philadelphia, Pa). 2003;23(4):495–502.
Au Eong KG, Beatty S, Charles SJ. Cytomegalovirus retinitis in patients with acquired immune deficiency syndrome. Postgrad Med J. 1999;75(888):585–90.
Boss JD, Rosenberg K, Shah R. Dual intravitreal injections with foscarnet and ganciclovir for ganciclovir-resistant recurrent cytomegalovirus retinitis in a congenitally infected infant. J Pediatr Ophthalmol Strabismus. 2016;53:e58–60. https://doi.org/10.3928/01913913-20161003-02.
Cannon MJ, Schmid DS, Hyde TB. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol. 2010;20(4):202–13. https://doi.org/10.1002/rmv.655.
Cheung CY, Wong IY, Yan KW, Kwong YL. Cytomegalovirus oral lesions: harbinger of retinitis in the absence of viraemia. Ann Hematol. 2014;93(9):1613–5. https://doi.org/10.1007/s00277-014-2008-1.
Freeman WR. Retinal detachment in cytomegalovirus retinitis: should our approach be changed? Retina (Philadelphia, Pa). 1999;19(4):271–3.
Freeman WR, Friedberg DN, Berry C, Quiceno JI, Behette M, Fullerton SC, Munguia D. Risk factors for development of rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis. Am J Ophthalmol. 1993;116(6):713–20.
Freeman WR, Quiceno JI, Crapotta JA, Listhaus A, Munguia D, Aguilar MF. Surgical repair of rhegmatogenous retinal detachment in immunosuppressed patients with cytomegalovirus retinitis. Ophthalmology. 1992;99(3):466–74.
Gross JG, Bozzette SA, Mathews WC, Spector SA, Abramson IS, McCutchan JA, Mendez T, Munguia D, Freeman WR. Longitudinal study of cytomegalovirus retinitis in acquired immune deficiency syndrome. Ophthalmology. 1990;97(5):681–6.
Hassan J, O’Neill D, Honari B, De Gascun C, Connell J, Keogan M, Hickey D. Cytomegalovirus Infection in Ireland: seroprevalence, HLA class I alleles, and implications. Medicine. 2016;95(6):e2735. https://doi.org/10.1097/md.0000000000002735.
Henry K, Cantrill H, Fletcher C, Chinnock BJ, Balfour HH Jr. Use of intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS. Am J Ophthalmol. 1987;103(1):17–23.
Holland GN, Buhles WC Jr, Mastre B, Kaplan HJ. A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy. Use of a standardized system for the assessment of disease outcome. UCLA CMV Retinopathy. Study Group. Arch Ophthalmol. 1989;107(12):1759–66.
Iu LP, Fan MC, Lau JK, Chan TS, Kwong YL, Wong IY. Long-term follow-up of cytomegalovirus retinitis in non-HIV immunocompromised patients: clinical features and visual prognosis. Am J Ophthalmol. 2016;165:145–53. https://doi.org/10.1016/j.ajo.2016.03.015.
Jabs DA, Enger C, Bartlett JG. Cytomegalovirus retinitis and acquired immunodeficiency syndrome. Arch Ophthalmol. 1989;107(1):75–80.
Jabs DA, Van Natta ML, Kempen JH, Reed Pavan P, Lim JI, Murphy RL, Hubbard LD. Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Am J Ophthalmol. 2002;133(1):48–61.
Jeon S, Lee WK, Lee Y, Lee DG, Lee JW. Risk factors for cytomegalovirus retinitis in patients with cytomegalovirus viremia after hematopoietic stem cell transplantation. Ophthalmology. 2012;119(9):1892–8. https://doi.org/10.1016/j.ophtha.2012.03.032.
Kangro HO, Osman HK, Lau YL, Heath RB, Yeung CY, Ng MH. Seroprevalence of antibodies to human herpesviruses in England and Hong Kong. J Med Virol. 1994;43(1):91–6.
Karavellas MP, Song M, Macdonald JC, Freeman WR. Long-term posterior and anterior segment complications of immune recovery uveitis associated with cytomegalovirus retinitis. Am J Ophthalmol. 2000;130(1):57–64.
Kempen JH, Jabs DA, Dunn JP, West SK, Tonascia J. Retinal detachment risk in cytomegalovirus retinitis related to the acquired immunodeficiency syndrome. Arch Ophthalmol. 2001;119(1):33–40.
Kempen JH, Jabs DA, Wilson LA, Dunn JP, West SK, Tonascia JA. Risk of vision loss in patients with cytomegalovirus retinitis and the acquired immunodeficiency syndrome. Arch Ophthalmol. 2003;121(4):466–76. https://doi.org/10.1001/archopht.121.4.466.
Korndewal MJ, Mollema L, Tcherniaeva I, van der Klis F, Kroes AC, Oudesluys-Murphy AM, Vossen AC, de Melker HE. Cytomegalovirus infection in the Netherlands: seroprevalence, risk factors, and implications. J Clin Virol. 2015;63:53–8. https://doi.org/10.1016/j.jcv.2014.11.033.
Kuppermann BD, Petty JG, Richman DD, Mathews WC, Fullerton SC, Rickman LS, Freeman WR. Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol. 1993;115(5):575–82.
Lieberman RM, Orellana J, Melton RC. Efficacy of intravitreal foscarnet in a patient with AIDS. N Engl J Med. 1994;330(12):868–9. https://doi.org/10.1056/nejm199403243301219.
Martin DF, Parks DJ, Mellow SD, Ferris FL, Walton RC, Remaley NA, Chew EY, Ashton P, Davis MD, Nussenblatt RB. Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. A randomized controlled clinical trial. Arch Ophthalmol. 1994;112(12):1531–9.
Miao H, Tao Y, Jiang YR, Li XX. Multiple intravitreal injections of ganciclovir for cytomegalovirus retinitis after stem-cell transplantation. Graefe’s archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle. Fortschr Ophthalmol. 2013;251(7):1829–33. https://doi.org/10.1007/s00417-013-2368-6.
Newsom R, Casswell T, O’Moore E, Fisher M. Cystoid macular oedema in patients with AIDS and cytomegalovirus retinitis on highly active antiretroviral therapy. Br J Ophthalmol. 1998;82(4):456–7.
Schwarcz L, Chen MJ, Vittinghoff E, Hsu L, Schwarcz S. Declining incidence of AIDS-defining opportunistic illnesses: results from 16 years of population-based AIDS surveillance. AIDS (London, England). 2013;27(4):597–605. https://doi.org/10.1097/QAD.0b013e32835b0fa2.
Shigemi D, Yamaguchi S, Otsuka T, Kamoi S, Takeshita T. Seroprevalence of cytomegalovirus IgG antibodies among pregnant women in Japan from 2009-2014. Am J Infect Control. 2015;43(11):1218–21. https://doi.org/10.1016/j.ajic.2015.06.026.
Stewart MW. Optimal management of cytomegalovirus retinitis in patients with AIDS. Clin Ophthalmol. 2010;4:285–99.
Tabatabaee M, Tayyebi D. Seroepidemiologic study of human cytomegalovirus in pregnant women in Valiasr Hospital of Kazeroon, Fars, Iran. J Matern Fetal Neonatal Med. 2009;22(6):517–21. https://doi.org/10.1080/14767050902801678.
Teoh SC, Wang PX, Wong EP. The epidemiology and incidence of cytomegalovirus retinitis in the HIV population in Singapore over 6 years. Invest Ophthalmol Vis Sci. 2012;53(12):7546–52. https://doi.org/10.1167/iovs.12-10349.
Wang B, Tian B, Tao Y, Hou J, Zhao XT, Li XX. Continued decline of aqueous interleukin-8 after multiple intravitreal injections of ganciclovir for cytomegalovirus retinitis. J Ocul Pharmacol Ther. 2014;30(7):587–92. https://doi.org/10.1089/jop.2013.0241.
Whitcup SM. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy. JAMA. 2000;283(5):653–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Wong, I.Y., Tao, Y. (2020). Human Immunodeficiency Virus Infection and Cytomegalovirus Retinitis. In: Yu, H. (eds) Inflammatory and Infectious Ocular Disorders. Retina Atlas. Springer, Singapore. https://doi.org/10.1007/978-981-13-8546-9_26
Download citation
DOI: https://doi.org/10.1007/978-981-13-8546-9_26
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-8545-2
Online ISBN: 978-981-13-8546-9
eBook Packages: MedicineMedicine (R0)